Wilson's disease overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 20: Line 20:


==Causes==
==Causes==
Wilson's disease is caused by ATP7B gene mutation and impairement of copper transportation.


==Differentiating ((Page name)) from Other Diseases==
==Differentiating Wilson's disease from Other Diseases==
Wilson's disease must be differentiated from other diseases that cause jaundice like hemochromatosis, viral hepatitis, alcoholic hepatitis, drug induced hepatitis, and autoimmune hepatitis.


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Revision as of 15:29, 26 December 2017

https://https://www.youtube.com/watch?v=Cr8R_bnKAtk%7C350}}


Wilson's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Wilson's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Wilson's disease overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wilson's disease overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wilson's disease overview

CDC on Wilson's disease overview

Wilson's disease overview in the news

Blogs on Wilson's disease overview

Directions to Hospitals Treating Wilson's disease

Risk calculators and risk factors for Wilson's disease overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Historical Perspective

Wilson's disease was first described by Dr. Samuel Alexander Kinnier Wilson where he described the pathological changes in the brain and liver in 1912. Many research studies revealed the correlation between ATP7B gene mutation and Wilson's disease. The first effective oral chelator was discovered by Dr. Walshe in 1956.

Classification

Wilson's disease is classified based on the symptomatic presentation into hepatic and neurologic Wilson's disease.

Pathophysiology

Causes

Wilson's disease is caused by ATP7B gene mutation and impairement of copper transportation.

Differentiating Wilson's disease from Other Diseases

Wilson's disease must be differentiated from other diseases that cause jaundice like hemochromatosis, viral hepatitis, alcoholic hepatitis, drug induced hepatitis, and autoimmune hepatitis.

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

There are no EKG findings associated with Wilson's disease. However, if the heart is affected by Wilson's disease, EKG should be performed to exclude any ongoing arrhythmias.

X-ray

There are no x-ray findings associated with Wilson's disease.

Ultrasound

CT scan

CT scan can be used in detecting abnormalities in the brain but MRI is more sensetive in diagnosing Wilm's tumor associated with neurological manifestations.

MRI

There are no specific MRI findings associated with Wilson's disease especially in cases who present with only hepatic manifestations. However, it may show abnormalities in the basal ganglia in the patients who presented with neuropsychiatric manifestations.

Other Imaging Findings

There are no other imaging findings associated with Wilson's disease.

Other Diagnostic Studies

Liver biopsy is performed in suspected cases of Wilson's disease as it may show many histopathological features. Liver biopsy may show mild steatosis, hepatocellular necrosis, macronodular cirrhosis, and fulminant liver failure features as parenchymal collapse. Genetic testing is also recommended in Wilson's disease to obtain the family history of the disease and for early detection.

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

References


Template:WikiDoc Sources

References

Template:WH Template:WS